메뉴 건너뛰기




Volumn 7, Issue 4, 2006, Pages 365-367

Methotrexate-induced pulmonary toxicity

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METHOTREXATE; PREDNISOLONE; STEROID;

EID: 33845359256     PISSN: 09723560     EISSN: 09723560     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (9)
  • 1
    • 0034955615 scopus 로고    scopus 로고
    • Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice
    • Grove ML, Hassel AB, Hay EM, Shadforth MF. Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice. Q J Med 2001; 94: 309-19.
    • (2001) Q J Med , vol.94 , pp. 309-319
    • Grove, M.L.1    Hassel, A.B.2    Hay, E.M.3    Shadforth, M.F.4
  • 3
    • 0028341809 scopus 로고
    • Opportunistic infection during treatment with low dose methotrexate
    • Lemense GP, Sahn SA. Opportunistic infection during treatment with low dose methotrexate. Am J Respir Crit Care Med 1994; 150: 258-60.
    • (1994) Am J Respir Crit Care Med , vol.150 , pp. 258-260
    • Lemense, G.P.1    Sahn, S.A.2
  • 4
    • 0023874002 scopus 로고
    • Methotrexate pneumonitis in rheumatoid: Potential risk factors
    • Searles G, McKendry RJ. Methotrexate pneumonitis in rheumatoid: potential risk factors. J Rheumatol 1987; 14: 1164-71.
    • (1987) J Rheumatol , vol.14 , pp. 1164-1171
    • Searles, G.1    McKendry, R.J.2
  • 6
    • 0032994881 scopus 로고    scopus 로고
    • Rheumatoid arthritis associated with methotrexate-induced pneumonitis: Improvement with I/V cyclophophamide therapy
    • Suwa A, Hirakata M, Satoh S et al. Rheumatoid arthritis associated with methotrexate-induced pneumonitis: improvement with I/V cyclophophamide therapy. Clin Exp Rheumatol 1999; 17: 355-8.
    • (1999) Clin Exp Rheumatol , vol.17 , pp. 355-358
    • Suwa, A.1    Hirakata, M.2    Satoh, S.3
  • 7
    • 1242342218 scopus 로고    scopus 로고
    • Reducing the risk of methotrexate pneumonitis in Rheumatoid Arthritis
    • Saravanan V, Kelly CA. Reducing the risk of methotrexate pneumonitis in Rheumatoid Arthritis. Rheumatology Journal 2004; 43: 143-7.
    • (2004) Rheumatology Journal , vol.43 , pp. 143-147
    • Saravanan, V.1    Kelly, C.A.2
  • 9
    • 0019799332 scopus 로고
    • A method for estimating the probability of adverse drug reaction
    • Naranjo CA et al. A method for estimating the probability of adverse drug reaction. Clinical Pharmacology and Therapeutics 1981; 30: 239-45.
    • (1981) Clinical Pharmacology and Therapeutics , vol.30 , pp. 239-245
    • Naranjo, C.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.